145986-11-4: Emtricitabine 5-Fluorouracil Analogue

145986-11-4: Emtricitabine 5-Fluorouracil Analogue

Emtricitabine 5-Fluorouracil Analogue (CAS No.143790-05-0) or 5-Fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolane-5-yl]uracil. Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) in combination with other antiviral agents it shows activity against HIV. It is approved for use in combination therapy.

Additional information on CAS 145986-11-4

Catalogue No.

VL54001
CAS No.

145986-11-4
Molecular Formula

C8H9FN2O4S
Molecular Weight

248.23
Parent drug

Emtricitabine
IUPAC Name

5-Fluoro-1-[(2R, 5S)-2-(hydroxymethyl)-1, 3-oxathiolane-5-yl]uracil
Synonyms

4-Hydroxyisophthalic acid; Acetylsalicylic Acid EP Impurity B; Aspirin Impurity B; Salicylic Acid Related Compound B; 4-Hydroxy-1, 3-benzenedicarboxylic Acid; 4-Hydroxy-m-phthalic Acid; Eupirina; NSC 2445; USP Salicylic Acid Related Compound B;
References

Bang, Lynne M., and Lesley J. Scott. “Emtricitabine.” Drugs, vol. 63, no. 22, 2003, pp. 2413–24, https://doi.org/10.2165/00003495-200363220-00003 Sax, Paul E., et al. “Coformulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide versus Dolutegravir with Emtricitabine and Tenofovir Alafenamide, for Initial Treatment of HIV-1 Infection (GS-US-380–1490): A Randomised, Double-Blind, Multicentre, Phase 3, Non-Inferiority Trial.” The Lancet, vol. 390, no. 10107, Nov. 2017, pp. 2073–82, https://d
Status

In-stock

Other products related to emtricitabine

[rfq_list]

Login first to add product to RFQ List

Request a quote

145986-11-4: Emtricitabine 5-Fluorouracil Analogue

145986-11-4: Emtricitabine 5-Fluorouracil Analogue
Catalogue No.

VL54001
CAS No.

145986-11-4
Molecular Formula

C8H9FN2O4S
Molecular Weight

248.23
Parent drug

Emtricitabine
IUPAC Name

5-Fluoro-1-[(2R, 5S)-2-(hydroxymethyl)-1, 3-oxathiolane-5-yl]uracil
Synonyms

4-Hydroxyisophthalic acid; Acetylsalicylic Acid EP Impurity B; Aspirin Impurity B; Salicylic Acid Related Compound B; 4-Hydroxy-1, 3-benzenedicarboxylic Acid; 4-Hydroxy-m-phthalic Acid; Eupirina; NSC 2445; USP Salicylic Acid Related Compound B;
References

Bang, Lynne M., and Lesley J. Scott. “Emtricitabine.” Drugs, vol. 63, no. 22, 2003, pp. 2413–24, https://doi.org/10.2165/00003495-200363220-00003 Sax, Paul E., et al. “Coformulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide versus Dolutegravir with Emtricitabine and Tenofovir Alafenamide, for Initial Treatment of HIV-1 Infection (GS-US-380–1490): A Randomised, Double-Blind, Multicentre, Phase 3, Non-Inferiority Trial.” The Lancet, vol. 390, no. 10107, Nov. 2017, pp. 2073–82, https://d
Status

In-stock
ListName

Emtricitabine 5-Fluorouracil Analogue
Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url
 
Hidden